Cisplatin in Combination With Zoledronic Acid: A Synergistic Effect in Triple-Negative Breast Cancer Cell Lines

International Journal of Oncology - Greece
doi 10.3892/ijo.2013.1809
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2018English

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

The Efficacy of Andrographolide and Its Combination With Betulinic Acid in the Treatment of Triple Negative Breast Cancer

Cancer therapy & Oncology International Journal
2017English

The Efficacy of Betulinic Acid in Triple-Negative Breast Cancer

SAGE Open Medicine
Medicine
2014English

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Oncotarget
Oncology
2014English

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells

Pharmaceutics
Pharmaceutical Science
2018English

Ciprofloxacin Inhibits Proliferation and Synergistic Effect Against Hepatocellular Carcinoma Cancer Lines With Cisplatin

African Journal of Pharmacy and Pharmacology
2013English

In Vivo Pulmonary Metastatic Profile of Breast Cancer Cell Lines Expressing Hormonal Receptors Versus Triple Negative

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy